Navigation Links
Crescendo Bioscience to present multiple studies at 2014 EULAR Meeting
Date:6/10/2014

r the following year. The new data from the SWEFOT study being presented at EULAR demonstrate that Vectra DA scores at 3 months and 12 months also were predictive of subsequent radiographic progression over the following 2 years. Additionally, patients in the SWEFOT study who did not respond to 3 months of initial methotrexate therapy were randomized to receive either non-biological DMARD triple therapy or anti-TNF (infliximab) therapy. Patients with a high Vectra DA score at baseline that remained high following therapy were at a high risk for radiographic progression. By contrast, risk for progression was significantly lower among patients with a high Vectra DA score at baseline, but lower Vectra DA score following treatment. At all measured time points, low Vectra DA scores were associated with low risk for subsequent radiographic progression.

"These are clinically relevant findings for rheumatologists taking care of patients with RA," said Ronald F. van Vollenhoven, M.D., Ph.D, Department of Medicine, Karolinska Institute in Stockholm, Sweden. "These data show that Vectra DA may help identify those patients at higher and lower risks for radiographic progression while receiving antirheumatic therapy."

Poster Tour Presentations

Title: Using the multi-biomarker disease activity score as a complementary inclusion criterion for clinical trials in rheumatoid arthritis may enhance recruitment.
Presenter: Ronald van Vollenhoven
Date: Presentation: June 13, 2014 12:00 PM, Room 251
Poster: June 14, 2014; 10:15 AM, Poster Area D, Level 4
Key Finding: In this analysis of the SWEFOT study, Vectra DA was found to be potentially useful as an inclusion criterion in clinical trials. Recruitment for clinical trials in patients with active RA may be enhanced by including patients with a Vectra DA score > 44 in addition to the conventional approach of only using patients with a CRP > 10 mg/L. This enhancement was achieved with
'/>"/>

Contact: Ronald Rogers
rrogers@myriad.com
801-584-3065
Myriad Genetics, Inc.
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Quincy Bioscience Announces the Kickoff of the Prevagen Blog
2. Quincy Bioscience Promotes Older Driver Safety Awareness Week
3. Dunn Foundation awards bioscience grants
4. Centrillion Biosciences Launches Cloud and Mobile-based Sequencing Application
5. Quincy Bioscience Makes Inc. 500
6. 5000 List of America’s Fastest Growing Companies
7. Quincy Bioscience Launches New Version of “The Brain Health Guide”
8. Quincy Bioscience Launches Complimentary Online Memory Games
9. Market Publishers Ltd and Select Biosciences Sign Partnership Agreement
10. NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation
11. Einstein & Montefiore present research at American Diabetes Association Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Calif. (PRWEB) September 17, 2014 ... monthly interruptions, giving girls of all ages an ... wellness company founded by women, for women, announces ... Uninterrupted® (http://GirlU.com) to relieve the symptoms ... bloating and irritability. , As a lifelong ...
(Date:9/17/2014)... 17, 2014 In a new video ... William Groff, an expert on the condition known as PPP, ... penile papules , or PPP, is a condition that affects ... men may be affected as well. The condition is characterized ... , “While PPP is not a sexually transmitted disease and ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 A raucous ... Disease come together to form author Nancy Chovancek’s laughter-filled ... book is a collection of short stories that prove ... on fun. With a positive message of empowerment and ... Chovancek is a proven author with two books under ...
(Date:9/17/2014)... GA (PRWEB) September 17, 2014 ... District (DHCHD) has implemented its CollaborNet™ Health ... exchange of patients’ health information between Coon Memorial ... Texas, and physicians in the community. , ... application to enable electronic referrals by physicians to ...
(Date:9/17/2014)... Seattle, Wa (PRWEB) September 17, 2014 ... published by the Telegraph in August 2014, scientists made ... cure for diabetes, but still failed. The article indicates ... , Despite this existing fact, there are many forward-thinking ... for diabetes treatment in a natural way. Dr. Kenneth ...
Breaking Medicine News(10 mins):Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 3Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 4Health News:New Video Depicts Best Treatment for PPP 2Health News:New Video Depicts Best Treatment for PPP 3Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 2Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 3Health News:Discover a Safe and Effective Treatment for Diabetes with The Diabetes Protocol – Vinamy 2
... 5 seek any assistance, MORAGA, Calif., Oct. 9 ... common disorders, it is regularly under diagnosed by,medical professionals., ... -- muscle tension,headache, nausea, fatigue, or trembling -- before ... during times of stress such as a,divorce, job change ...
... Results of a multicenter study led by Johns Hopkins ... babies with hydrocortisone, a steroid believed to fight inflammation ... treatment offers little or no benefit and that low ... levels, on the other hand, appeared to increase the ...
... New Report Shows Only 17% of Employers Offer Vision Benefits, ... have taken center stage in the upcoming election, worries about,the ... minds of most,Americans. For the 120 million Americans with vision ... value on maintaining healthy vision,the lack of vision coverage is ...
... Generations agrees to sell patents to Life Spine, ... firm Life Spine, Inc. announced today that it has ... LLC. Terms of,the transaction were not disclosed., According ... property expansion is critical. "The core of the spine ...
... Oct. 8 The Hain Celestial,Group, Inc. (Nasdaq: ... food and personal,care products company, today announced that ... to make a presentation regarding the,Company on Wednesday, ... Natural Boston Conference., (Logo: http://www.newscom.com/cgi-bin/prnh/20050324/NYTH131 ...
... Predictive medicine company,PreMD Inc. (TSX: PMD; PREMF.pk) ... has completed its previously announced debenture financing ... Midsummer,Investment, Ltd. The gross proceeds of the ... general corporate purposes., "We are very ...
Cached Medicine News:Health News:40 Million Americans Endure Anxiety Everyday 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 3Health News:Americans Place High Value on Eyesight, Yet Many Still Lack Vision Coverage 2Health News:Americans Place High Value on Eyesight, Yet Many Still Lack Vision Coverage 3Health News:Hain Celestial to Present at Canaccord Adams Healthy Living Naturally Boston Conference on October 15, 2008 2Health News:PreMD Inc. Completes Secured Debenture Financing 2
(Date:9/16/2014)... , Sept. 16, 2014 This report analyzes the ... by the following Product Segments: SPECT Systems (Includes SPECT and ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2013 through ...
(Date:9/16/2014)... -- Chairman and CEO Bernard J. Tyson announced ... the role of interim chief information officer (CIO) for ... "Kaiser Permanente is a recognized leader ... high-quality care and service we provide to our 9.5 ... extensive experience in information technology. I am confident that ...
(Date:9/16/2014)... 16, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... on licensing, developing and commercializing innovative biopharmaceutical products ... commencing an underwritten registered public offering of shares ... are being offered by Aratana Therapeutics. ... joint book-running managers for the offering.  ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Name Interim Chief Information Officer 2Aratana Therapeutics, Inc. Announces Proposed Public Offering 2
... LLC, a global leader in,non invasive high intensity ... of the Sonablate(R) International HIFU Registry,(SIHR), along with ... Takai,Hospital Supply Co., Ltd., (THS). The SIHR is ... about prostate cancer treatment using HIFU.,It was established ...
... candidates to ... obesity patients, SAN DIEGO, July 9 Orexigen(R) Therapeutics,Inc. ... randomizing patients,in ZB-202, a second Phase IIb clinical trial for ... trial is designed,to build on highly encouraging safety and efficacy ...
Cached Medicine Technology:Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 2Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 3Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule 2Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule 3Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule 4
Cholesterol FS. For determination of cholesterol in serum or plasma. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P Trulab L....
Intended for the quantitative determination of total cholesterol in serum. Single vial, dry powder reagent. Reaction: Endpoint. Wavelength: 500 nm. Linearity: 700 mg/dL (12.9 mmol/L)....
This true 8-bit integrated and cooled imaging system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lightin...
... range of Platelet aggregometers allows to ... particular needs. Single, dual and four ... recorder outputs or digital computer outputs. ... aggregometers, which measure platelet aggregation in ...
Medicine Products: